Maynard Um
-
-
-
-
-
-
-
AbbVie (ABBV) call put ratio 1 call to 1 put into quarter results
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $261 at Guggenheim
-
-
-
-
-
-
-
FDA approves AbbVie's Skyrizi for children with psoriatic disease
-
-
-
-
-
-
-
AbbVie (ABBV) call put ratio 2.2 calls to 1 put into near deal to acquire Apogee Therapeutics (APGE), FT reports
-
-
-
-
-
-
-
AbbVie to present oncology pipeline data at 2026 ASCO meeting
-
-
-
-
-
-
-
Abbvie (ABBV) PT Raised to $244 at Goldman Sachs
-
-
-
-
-
-
-
AbbVie to build $1.4 billion manufacturing campus in North Carolina
-
429,939 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

